Clinical trial PEARL
The PEARL study : Pet imaging as a biomarker of Everolimus Added value in hormone Refractory postmenopausaL women
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Institut Jules Bordet |
| EudraCT Identifier | 2012-004860-22 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02028364 |
| Inclusion criteria | ER+/HER2- |
| Last update |